Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Oleksandra Kutsenko

Diagnostic Radiology Las Vegas, NV Medical Doctor

NPI 1598116527 CMS profile 10327261

3100 N Tenaya Way, Las Vegas, NV 89128

Open in the dashboard

General payments

$26,175

270 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Oleksandra Kutsenko of Las Vegas, NV is reported in the CMS Open Payments database as having received $26,175 across 270 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,653 63
2024 General $7,814 60
2023 General $6,932 72
2022 General $3,420 60
2021 General $355 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Oleksandra Kutsenko
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Oleksandra Kutsenko were reported at $7,653. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Oleksandra Kutsenko Diagnostic Radiology median Middle half National median
2019 $0 $108 $29–$318 $163
2020 $0 $65 $21–$252 $114
2021 $355 $92 $24–$292 $132
2022 $3,420 $104 $29–$294 $149
2023 $6,932 $110 $29–$337 $160
2024 $7,814 $113 $30–$356 $164
2025 $7,653 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Sirtex Medical Inc $5,962 37 payments
  2. Boston Scientific Corporation $4,843 41 payments
  3. Penumbra, Inc. $2,666 26 payments
  4. Medtronic, Inc. $1,848 25 payments
  5. Inari Medical, Inc. $1,660 19 payments
  6. Balt USA, LLC $1,339 11 payments
  7. AngioDynamics, Inc. $1,299 9 payments
  8. Cook Medical LLC $1,123 18 payments
  9. Stryker Corporation $1,072 20 payments
  10. Cook Incorporated $901 6 payments
  11. Other $3,461 58 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $20,838 256 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,000 1 payment
  3. Travel and Lodging $2,337 13 payments
Products named General payments · program years 2021–2025
  1. SIR-Spheres Microspheres $5,813 36 payments
  2. TheraSphere Y90 Glass Microspheres 10 GBq $2,792 12 payments
  3. CT THROMBECTOMY SYSTEM KIT $2,152 27 payments
  4. FLOWTRIEVER CATHETER, S $2,152 27 payments
  5. Indigo System $1,726 17 payments
  6. Prestige Coil System $1,339 11 payments
  7. Zenith $878 8 payments
  8. Rosch-Uchida $859 7 payments
  9. ENDURANT IIS $737 10 payments
  10. ALPHAVAC $721 5 payments
  11. Other $8,433 129 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

30

Median for Diagnostic Radiology: 24

Drug cost

$172

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 13 $95
Levofloxacin Generic 17 $77

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 108 billing codes

Paid by Medicare

$48,575

Medicare's payments for the services billed

Medicare patients

425

Average age 73

Services billed

845

222 women, 203 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 58%
Arthritis 56%
Ischemic heart disease 55%
Heart failure 54%
Chronic kidney disease 53%
Atrial fibrillation 41%
COPD 40%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

270 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record